2688-6146

eJHaem

Wiley (John Wiley & Sons)

View prefix report (10.1002)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 509 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact509 DOIs
2

Attach ORCID iDs across 276 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact276 DOIs
3

Deposit reference lists for 247 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact247 DOIs

DOIs for this ISSN

Showing the top 5 of 1423 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 CAR T cell therapy in solid tumors: A review of current clin… (10.1002/jha2.356)
ORCID
51.98 119
2 Overview of approved CAR‐T therapies, ongoing clinical trial… (10.1002/jha2.338)
ORCID
51.33 112
3 Cutaneous cryptococcosis in a patient with myelofibrosis rec… (10.1002/jha2.339)
Abstract References ORCID
45.15 3
4 Disseminated histoplasmosis mimicking hematologic malignancy… (10.1002/jha2.389)
Abstract References
38.91 5
5 CAR‐T‐OPENIA: Chimeric antigen receptor T‐cell therapy‐assoc… (10.1002/jha2.350)
ORCID
36.56 28
6 Multiple cytogenetics forms of <i>KMT2A</i> amplification an… (10.1002/jha2.313)
Abstract References ORCID
35.78 2
7 Vexas: A new syndrome not always associated with hemopathy (10.1002/jha2.341)
Abstract References ORCID
35.78 2
8 Hypermetabolic lymphadenopathy on positron emission tomograp… (10.1002/jha2.268)
Abstract References
34.95 4
9 Systematic literature review of quality‐of‐life questionnair… (10.1002/jha2.668)
Abstract ORCID
34.95 4
10 Transverse myelitis after anti‐CD19 directed CAR T cell ther… (10.1002/jha2.286)
Abstract
33.06 20
11 A review of the incidence of tumor lysis syndrome in patient… (10.1002/jha2.427)
ORCID
30.76 16
12 A real‐world study to assess the association of cardiovascul… (10.1002/jha2.638)
ORCID
30.76 16
13 <i>Scedosporium apiospermum</i> brain abscesses in a patient… (10.1002/jha2.121)
Abstract References
30.10 3
14 Blast phase of chronic myeloid leukemia presenting as early… (10.1002/jha2.324)
Abstract References
30.10 3
15 Colonic myeloid sarcoma with mutated <i>NPM1</i> manifesting… (10.1002/jha2.377)
Abstract References
30.10 3
16 Autologous stem cell transplantation in a patient with scler… (10.1002/jha2.463)
Abstract References
30.10 3
17 Lymphadenopathy with florid lymphoid and Langerhans cell hyp… (10.1002/jha2.265)
Abstract
28.65 13
18 SARS‐CoV‐2 infection results in upregulation of Plasminogen… (10.1002/jha2.654)
ORCID
28.65 13
19 Sickle cell disease and COVID‐19: Atypical presentations and… (10.1002/jha2.74)
Abstract
28.65 13
20 Iron deficiency anemia from iron malabsorption caused by pro… (10.1002/jha2.96)
ORCID
28.65 13
21 GDF‐15 is associated with atherosclerosis in adults with tra… (10.1002/jha2.415)
ORCID
27.85 12
22 First report of teclistamab in a patient with relapsed AL am… (10.1002/jha2.772)
Abstract
26.98 11
23 Lessons learnt from COVID‐19 coagulopathy (10.1002/jha2.228)
ORCID
26.03 10
24 Primary splenic diffuse large B‐cell lymphoma presenting as… (10.1002/jha2.642)
ORCID
26.03 10
25 The effect of underlying inflammation on iron metabolism, ca… (10.1002/jha2.257)
ORCID
25.00 9
26 Lymphoplasmacytic lymphoma and marginal zone lymphoma involv… (10.1002/jha2.573)
ORCID
25.00 9
27 HIV‐associated Burkitt lymphoma in the combination antiretro… (10.1002/jha2.624)
ORCID
25.00 9
28 Spheroacanthocytes secondary to novel tyrosine kinase inhibi… (10.1002/jha2.104)
Abstract References
23.86 2
29 Multiple myeloma with G‐CSF production mimicking chronic neu… (10.1002/jha2.171)
Abstract References
23.86 2
30 Axillary lymph nodes on PET in Hodgkin lymphoma after COVID‐… (10.1002/jha2.297)
Abstract References
23.86 2
31 Intravascular large B‐cell lymphoma treated with polatuzumab… (10.1002/jha2.301)
Abstract References
23.86 2
32 <sup>18</sup>FDG‐avid cholesterol granuloma mimicking residu… (10.1002/jha2.332)
Abstract References
23.86 2
33 Cytokeratin‐positive follicular dendritic cell sarcoma: A mi… (10.1002/jha2.344)
Abstract References
23.86 2
34 Treatment Response Assessment Maps (TRAMs), a new tool for C… (10.1002/jha2.346)
Abstract References
23.86 2
35 Mast cell density and its clinical relevance in Waldenström'… (10.1002/jha2.378)
ORCID
23.86 8
36 Hematidrosis as a manifestation of COVID‐19 containment‐indu… (10.1002/jha2.45)
Abstract References
23.86 2
37 Erythropoietin‐induced pure red cell aplasia (10.1002/jha2.481)
Abstract References
23.86 2
38 Transformation of myelodysplastic syndrome to mixed phenotyp… (10.1002/jha2.59)
Abstract References
23.86 2
39 How will UK hospitals use andexanet alfa? A review of local… (10.1002/jha2.648)
Abstract
23.86 8
40 Community‐level socioeconomic distress is associated with nu… (10.1002/jha2.661)
ORCID
23.86 8
41 Lynozyfic (Linvoseltamab): A First‐in‐Class Off‐the‐Shelf T‐… (10.1002/jha2.70182)
Abstract ORCID
23.86 2
42 Impressive extramedullary plasmacytoma response in refractor… (10.1002/jha2.821)
Abstract References
23.86 2
43 Increased body mass index is a risk factor for acute promyel… (10.1002/jha2.163)
ORCID
22.58 7
44 Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearran… (10.1002/jha2.513)
Abstract References ORCID
22.58 1
45 Acquired L1196M <i>ALK</i> mutation in anaplastic lymphoma k… (10.1002/jha2.646)
Abstract
22.58 7
46 Finding balance between mature and immature neutrophils: The… (10.1002/jha2.649)
Abstract
22.58 7
47 Correction to “Weight Loss and Dysgeusia in Relapsed/Refract… (10.1002/jha2.70052)
Abstract References ORCID
22.58 1
48 Bleeding outcomes in thrombocytopenic acute leukemic patient… (10.1002/jha2.90)
ORCID
22.58 7
49 Presentation, management, and outcomes of COVID‐19 in patien… (10.1002/jha2.162)
Abstract
21.13 6
50 COVID‐19‐associated pseudothrombocytopenia (10.1002/jha2.239)
Abstract
21.13 6